BENATI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 4.328
EU - Europa 2.242
AS - Asia 1.762
SA - Sud America 304
OC - Oceania 31
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.699
Nazione #
US - Stati Uniti d'America 4.278
IT - Italia 692
GB - Regno Unito 568
CN - Cina 566
SG - Singapore 541
HK - Hong Kong 301
BR - Brasile 235
SE - Svezia 213
DE - Germania 181
VN - Vietnam 137
RU - Federazione Russa 123
FR - Francia 102
UA - Ucraina 92
NL - Olanda 58
FI - Finlandia 43
KR - Corea 40
CA - Canada 34
BG - Bulgaria 33
AU - Australia 31
IN - India 31
ID - Indonesia 30
TR - Turchia 27
AR - Argentina 23
BE - Belgio 22
JP - Giappone 22
IE - Irlanda 21
ES - Italia 14
LT - Lituania 14
ZA - Sudafrica 14
AT - Austria 13
CH - Svizzera 13
EC - Ecuador 12
CZ - Repubblica Ceca 11
MX - Messico 11
CO - Colombia 10
NP - Nepal 10
BD - Bangladesh 9
JO - Giordania 6
PY - Paraguay 6
UY - Uruguay 6
AL - Albania 5
IR - Iran 5
MA - Marocco 5
MY - Malesia 5
PK - Pakistan 5
PL - Polonia 5
SA - Arabia Saudita 5
TN - Tunisia 5
TW - Taiwan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
IQ - Iraq 4
PE - Perù 4
DK - Danimarca 3
GR - Grecia 3
LV - Lettonia 3
BY - Bielorussia 2
BZ - Belize 2
CL - Cile 2
KE - Kenya 2
LK - Sri Lanka 2
RO - Romania 2
RS - Serbia 2
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.699
Città #
Santa Clara 535
Fairfield 473
Ashburn 404
Singapore 387
Southend 362
Hong Kong 293
Chandler 261
Woodbridge 217
Houston 200
Seattle 168
Wilmington 165
Nyköping 164
Cambridge 156
Hefei 156
Dearborn 148
Jacksonville 144
London 112
Beijing 109
Bologna 95
Ann Arbor 89
Modena 68
Los Angeles 61
New York 58
Ho Chi Minh City 51
San Diego 51
Princeton 40
Helsinki 36
Sofia 33
Eugene 31
Munich 30
Seoul 30
Milan 29
Moscow 29
Chicago 28
Jakarta 26
The Dalles 26
Hanoi 25
Shanghai 24
Buffalo 22
Brussels 21
Parma 21
São Paulo 21
Falls Church 19
Izmir 17
Queens 17
Redondo Beach 17
Bremen 16
Council Bluffs 16
Dallas 16
Dublin 15
Orem 15
Rome 15
Tokyo 15
Paris 14
Redwood City 14
San Francisco 14
Toronto 14
Boardman 13
Nuremberg 13
Phoenix 13
Portsmouth 13
Lauterbourg 12
Tampa 12
Adelaide 11
Reggio Emilia 11
Guangzhou 10
Amsterdam 9
Brno 9
Columbus 9
Piacenza 9
Rio de Janeiro 9
Vienna 9
Wuhan 9
Atlanta 8
Boston 8
Brooklyn 8
Des Moines 8
Dong Ket 8
Montreal 8
Napoli 8
Salt Lake City 8
San Jose 8
Stockholm 8
Trento 8
Turin 8
Canberra 7
Denver 7
Elk Grove Village 7
Guayaquil 7
Johannesburg 7
Kent 7
Padova 7
Sydney 7
Amman 6
Amstelveen 6
Brasília 6
Broomfield 6
Chennai 6
Formigine 6
Haiphong 6
Totale 5.998
Nome #
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 379
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 355
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 346
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 321
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 292
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 246
Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia 229
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 223
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 219
DNA vaccination by electroporation amplifies broadly cross-restricted public TCR clonotypes shared with HIV Controllers 216
CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers 211
A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers 210
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 209
Public T cell receptors confer high-avidity CD4 responses to HIV controllers 208
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 203
The shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation 198
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 198
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 195
MHC Class II Tetramer Labeling of Human Primary CD4+ T Cells from HIV Infected Patients 193
The strepsipteran endoparasite Xenos vesparum alters the immunocompetence of its host, the paper wasp Polistes dominulus 191
HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term 187
Gene editing prospects for treating inherited retinal diseases 184
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases 179
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 167
Comparison of the antigen sensitivity of Gag-specific CD4+ T cell responses in controlled HIV infection and HIV vaccination 166
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 165
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation 165
Characterization of high avidity CD4+ T cells in HIV Controllers 161
SRC family kinases as potential therapeutic targets for malignancies and immunological disorders 152
Specific cTfh frequency correlates with memory B cell responses in HIV controllers. 150
T cell receptors from the HIV-specific repertoire, means for their production and therapeutic uses thereof 150
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 149
SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling 144
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 144
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 139
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 136
Frequent sharing of high-affinity TCRs in naturally controlled HIV infection: implications for vaccination 133
HIV Controller CD4+ T cells preferentially express a public TCR clonotype that confers high avidity responses against Gag 132
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 131
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 129
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 127
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 124
Molecular characterization of high avidity CD4+ T cells in HIV Controllers 121
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 111
Public TCRs confer high-avidity CD4 responses to HIV controllers 108
Erratum: Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases (European Journal of Immunology (2006) vol. 36 (11) 10.1002/eji.200636567)) 106
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 99
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 88
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 21
Totale 8.810
Categoria #
all - tutte 36.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021494 0 0 0 0 0 62 54 110 43 104 83 38
2021/2022797 54 91 61 23 42 47 55 40 85 59 148 92
2022/20231.005 108 102 98 87 123 115 29 69 125 19 64 66
2023/2024671 32 53 55 64 94 30 48 85 20 32 59 99
2024/20252.027 64 40 76 121 373 315 169 127 215 130 173 224
2025/20261.589 238 103 260 419 523 46 0 0 0 0 0 0
Totale 8.810